Literature DB >> 1005930

Different response of hepatic energy change and adenine nucleotide concentrations to hemorrhagic shock.

K Ozawa, T Ida, T Kamano, J Garbus, R A Cowley.   

Abstract

The adenine nucleotide and mitochondrial metabolisms of the liver were studied in hemorrhagic shock of rats. In reversible shock, the energy charge (ATP+1/2ADP/ATP+ADP+AMP) levels fell more rapidly than the total adenine nucleotide concentrations and decreased to 64% of controls 2 hours after shock. However, the oxidative phosphorylation of isolated mitochondira was only slightly inhibited. The energy charge levels were restored to normal values immediately when the shed blood was reinfused, while the concentrations of adenine nucleotides increased gradually and reached normal at 2 hours later. In irreversible shock which took up 70% or more of the withdrawn blood to maintain pressure of 40mm. Hg, the energy charge, adenine nucleotide concentrations and mitochondrial oxidative phosphorylation decreased considerably and were not restored by the reinfusion of the remainder of shed blood. It is suggested that the energy charge can respond rapidly to changes in an available oxygen and the adenine nucleotide concentrations and that an impairment of mitochondrial oxidative phosphorylation plays an important role in leading to irreversible hemorrhagic shock.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1005930     DOI: 10.1007/bf01851175

Source DB:  PubMed          Journal:  Res Exp Med (Berl)        ISSN: 0300-9130


  2 in total

1.  Arterial ketone body ratio as a parameter of hepatic mitochondrial redox state during and after hemorrhagic shock.

Authors:  T Nakatani; L Spolter; K Kobayashi
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

2.  Ringer's lactate solution enhances the inflammatory response during fluid resuscitation of experimentally induced haemorrhagic shock in rats.

Authors:  Krzysztof Kusza; Mariusz Mielniczuk; Lukasz Krokowicz; Jacek B Cywiński; Maria Siemionow
Journal:  Arch Med Sci       Date:  2017-09-05       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.